Description
VS-5584 inhibits PI3K and displays anticancer chemotherapeutic activity, inhibiting cell proliferation in a variety of cancer cell lines and suppressing tumor growth in animal models of gastric cancer.
| Product Unit Size | Cost | Quantity | Stock |
|---|
VS-5584 inhibits PI3K and displays anticancer chemotherapeutic activity, inhibiting cell proliferation in a variety of cancer cell lines and suppressing tumor growth in animal models of gastric cancer.
| Cas No. | 1246560-33-7 |
|---|---|
| Purity | ≥98% |
| Formula | C17H22N8O |
| Formula Wt. | 354.41 |
| IUPAC Name | 5-(8-methyl-2-morpholin-4-yl-9-propan-2-ylpurin-6-yl)pyrimidin-2-amine |
| Synonym | SB2343, SB-2343, VS5584 |
| Solubility | DMSO 71 mg/mL (200.33 mM) Ethanol 3 mg/mL (8.46 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Hart S, Novotny-Diermayr V, Goh KC, et al. VS-5584, a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer. Mol Cancer Ther. 2013 Feb;12(2):151-61. PMID: 23270925.
Abl, c-Kit, PDGFR inhibitor.
11β-HSD1 inhibitor.
(S) isomer of omeprazole; H+/K+ ATPase and MAO-...
Synthetic peptice; μOR agonist.
Furocoumarin; voltage-gated Na+ channel blocker...
Statin; HMG-CoA reductase inhibitor, potential ...
Antifungal antibiotic
Peptide, derivative of AT I, cleavage product o...
Polyphenol found in many plants and foods.
Toxin found in Aconitum; voltage-gated Na+ chan...
RyR agonist, SIRT, telomerase, P2Y, GPCR inhibi...
Endogenous glycoprotein; lactoferrin agonist.
β-adrenergic antagonist.
Peptide, contains two cell-penetrating sequence...
Endogenous neuropeptide, also known as substanc...
B-Raf and c-Raf inhibitor.
Thienylbutyl ITC analog.
Cembranoid diterpene found in Sarcophyton glauc...
Peptide; calcineurin inhibitor.
Triterpene glycoside found in Glycyrrhiza; 15-H...